Saudi Gazette report RIYADH — The Saudi Food and Drug Authority (SFDA) has approved the registration of the first-of-its-kind clinical study (Phase I) of an investigational gene therapy, thanks to its
Keep Up to Date with our Weekly Newsletter
SFDA approves clinical trial for a gene therapy developed in Saudi Arabia to treat acute lymphoblastic leukemia
